Navigation Links
Epigenetics: Changing the Way We Think about DNA
Date:3/7/2013

Irvine, CA (PRWEB) March 07, 2013

Zymo Research Corporation, a privately held company located in Irvine, California, has recently expanded its range of tools and services for scientists working in one of the hottest fields of science today – Epigenetics. Zymo Research now offers the most comprehensive suite of services for epigenetic analysis, including genome-wide platforms for profiling DNA methylation and hydroxymethylation, ChIP-Seq, nucleosome mapping, RNA-Seq, and more. These services are intended to assist academic and industry scientists investigate the role epigenetics plays in a variety of applications – one of the largest being healthcare. Epigenetics research has the potential to completely revolutionize modern medicine through the advancement of personalized therapies, cancer treatment, stem cell research, and drug development.

As one of the Top 10 Scientific Discoveries of 2009, according to TIME magazine, efforts to decode the epigenome are notably one of the most exciting and rapidly expanding areas in biology. While it was previously believed that the primary DNA sequence contained all of the information required for heredity, scientists now agree that genetics alone can never fully explain why we develop as we do. Now, epigenetics can help provide answers to questions such as why identical twins that share the same DNA sequence can end up developing differently and why some of us develop cancers and various other diseases, while others do not. Furthermore, the study of this field may answer the age-old question of nature versus nurture and how environmental factors such as nutrition, stress, age, and illness can cause heritable traits without changing the underlying DNA sequence.

According to Dr. Marc Van Eden, V.P. of Business Development at Zymo Research, “Making genome-wide epigenetic analyses available to all researchers will mark the beginning of a new era in epi-biomarker discovery and validation that will aid in the diagnostics and prognostics of human diseases. Epigenetics research will also facilitate advancements in personalized medicine and companion diagnostics to optimize the efficiency of individualized drug treatment. We may begin to ask how things like the environment and our diet affect who we are and who we will likely become.” With genome-wide and targeted epigenetic sequencing services, companies like Zymo Research make profiling the epigenome of patients a reality. Such advancements will become crucial in furthering our understanding of science and medicine and should have a significant impact on how we diagnose and treat human diseases in the future.

For more information or to inquire about the epigenetic services, please contact Zymo Research at:

services(at)zymoresearch(dot)com
Tel: (949) 679-1190
Toll free: (888) 882-9682
http://www.zymoresearch.com/services

Zymo Research Corporation is a privately held biotechnology company located in Irvine, California that provides the highest quality epigenetics products and services, in addition to DNA and RNA purification products. The philosophy of the company is to provide the most innovative, quality products, while ensuring they are both simple and reliable to use.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10496662.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
2. Changing our material future, layer by layer
3. Fast forward to the past: NASA technologists test game-changing data-processing technology
4. A new take on the Midas touch -- changing the color of gold
5. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
6. Rethinking bacterial persistence
7. Probiotic Action Discusses Using Social Media to Teach the Public about Acne
8. Forget about leprechauns, engineers are catching rainbows
9. A gut feeling about neural stem cells
10. Genuine Bio-Fuel Clears the Air About Biodiesel In Wake of Recent Turmoil
11. Unknown Facts About Chronic Low Back Pain Treatment Revealed by the Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):